USPTO serial 99693452
ABBEXA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 6, 2026
- Examiner
- RAMOS, STEPHEN NMN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ABBEXA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Sugar Land, TX, US
Cambridge, GB
Cambridge, GB
Cambridge, GB
Sugar Land, TX, US
Sugar Land, TX, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Monoclonal antibodies for scientific purposes; Antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; Biochemicals for use in industry and science; Biochemicals for in vitro and in vivo scientific use; Biochemical catalysts; Biochemical preparations for scientific purposes; Peptide substrates for scientific purposes; Testing kits comprising peptide substrates used in analyzing and detecting certain toxins for research purposes; Diagnostic preparations in the nature of peptide substrates, other than for medical or veterinary purposes; Protein plastics; Protein in raw material form for scientific and medical research; Chemicals for use in the purification of proteins for in vitro use; Protein for industrial use; Proteins for use in the manufacture of assays.; Proteins for use in manufacture; Proteins for the food industry; Enzymes for use in protein hydrolysis; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Amino acids, other than for medical or veterinary purposes; Assays for research purposes; Assays and reagents for use in genetic research; Assays for scientific and research use; Reagents for scientific and research use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Chemical reagents, other than for medical or veterinary purpose; Reagents for scientific or medical research use; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Cell culture reagents for scientific and research use; Biochemical reagents used for non-medical purposes; Reagent bearing diagnostic strips for testing breast milk, other than for medical or veterinary use; Reagents for blood grouping, other than for medical or veterinary purposes; Reagents for blood typing, other than for medical or veterinary purposes; Cell culture reagents for scientific or research purposes; Cells for scientific, laboratory or medical research; Cell growth media for growing cells for scientific and research use; Enzymes for scientific and research purposes; Fluorescent dye for scientific or research use; Specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; Assays for testing protein concentrations, namely Enzyme-Linked Immunosorbent Assay (ELISA) kits, other than for medical or veterinary use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Biological tissue, namely, animal blood products for use in scientific and medical research | ACTIVE | Apr 5, 2013 |
| 035 | On-line ordering services featuring antibodies and reagents for scientific research purposes; web-based catalogue services featuring antibodies, proteins, Enzyme-Linked Immunosorbent Assay (ELISA) kits, peptides, enzymes, lysates, tissues, lipids, vectors, assay kits, reagents, control reagents, small molecules, cells, genes, cells/tissue arrays all for medical, diagnostic and scientific research purposes | ACTIVE | Apr 5, 2013 |
| 042 | Providing scientific information in the field of biology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing information about medical and scientific research; Providing scientific research information in the field of biology; Providing information about medical and scientific research via a website; Providing scientific research information | ACTIVE | Apr 5, 2013 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Abbexa LLC
- Other trademarks owned by Abbexa Ltd
- Other trademarks owned by Abbexa Ltd
- Other trademarks owned by Abbexa Ltd
- Other trademarks owned by Abbexa LLC
- Other trademarks owned by Abbexa LLC
- Other trademarks in Class 001
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named ABBEXA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 6, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 18, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 12, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 20, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 17, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 17, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 17, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 17, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 16, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 10, 2026 | NWAP | NEW APPLICATION ENTERED | — |